InsiderTrades.com logo
$2 Trillion Disappears Because of Fed's Secretive New Move
From Stansberry Research   |   Ad
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being carried out by the Fed that has nothing to do with lowering or raising interest rates... but could soon have an enormous impact on your wealth.
Click here to see his new research now.

ANEB Insider Trading

Insider Ownership Percentage: 85.90%
Insider Buying (Last 12 Months): $9,999,999.90
Insider Selling (Last 12 Months): $0.00

Anebulo Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Anebulo Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Anebulo Pharmaceuticals Share Price & Price History

Current Price: $1.70
Price Change: ▲ Price Increase of +0.08 (4.94%)
As of 12/27/2024 06:45 PM ET

This chart shows the closing price history over time for ANEB up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Why Buffett, Griffin and 100 members of Congress are Piling into this One Investment
From Behind the Markets   |   Ad
This isn't just another investment. It might be the last retirement stock you'll ever need. But this window of opportunity is closing fast.
Click here for the ticker >>>

Anebulo Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/23/2024Aron R. EnglishDirectorBuy10,101,010$0.99$9,999,999.9015,467,300View SEC Filing Icon  
See Full Table
Why Buffett, Griffin and 100 members of Congress are Piling into this One Investment
From Behind the Markets   |   Ad
This isn't just another investment. It might be the last retirement stock you'll ever need. But this window of opportunity is closing fast.
Click here for the ticker >>>

SEC Filings (Institutional Ownership Changes) for Anebulo Pharmaceuticals (NASDAQ:ANEB)

28.40% of Anebulo Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ANEB by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Anebulo Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
1/16/2024LVW Advisors LLC643,039$1.56M0.3%-4.4%2.509%Search for SEC Filing on Google Icon
2/8/2023Herr Investment Group LLC29,644$72K0.0%N/A0.116%Search for SEC Filing on Google Icon
11/10/2022Nantahala Capital Management LLC511,073$1.43M0.1%N/A1.994%Search for SEC Filing on Google Icon
10/14/2022LVW Advisors LLC674,964$1.89M0.4%-3.6%2.888%Search for SEC Filing on Google Icon
7/22/2022LVW Advisors LLC700,000$3.64M0.7%N/A2.999%Search for SEC Filing on Google Icon
8/18/2021Ikarian Capital LLC174,811$1.20M0.1%N/A0.749%Search for SEC Filing on Google Icon
8/17/202122NW LP3,343,565$22.80M6.1%N/A14.322%Search for SEC Filing on Google Icon
8/17/2021Boothbay Fund Management LLC19,835$0.14M0.0%N/A0.085%Search for SEC Filing on Google Icon
8/13/2021Laurion Capital Management LP225,000$1.55M0.0%N/A0.964%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Anebulo Pharmaceuticals logo
Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing solutions for people suffering from acute cannabinoid intoxication (ACI) and substance addiction. The company's lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist, which is in a Phase II clinical trial to address the unmet medical need for a specific antidote for ACI. Anebulo Pharmaceuticals, Inc. was incorporated in 2020 and is based in Lakeway, Texas.
Read More on Anebulo Pharmaceuticals

Today's Range

Now: $1.70
Low: $1.63
High: $1.85

50 Day Range

MA: $1.57
Low: $0.99
High: $1.90

52 Week Range

Now: $1.70
Low: $0.80
High: $3.30

Volume

90,542 shs

Average Volume

10,916 shs

Market Capitalization

$44.09 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Anebulo Pharmaceuticals?

Anebulo Pharmaceuticals' top insider investors include:
  1. Aron R English (Director)
Learn More about top insider investors at Anebulo Pharmaceuticals.
$2 Trillion Disappears Because of Fed's Secretive New Move
From Stansberry Research   |   Ad
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being carried out by the Fed that has nothing to do with lowering or raising interest rates... but could soon have an enormous impact on your wealth.
Click here to see his new research now.